Population-based BRCA1/2 testing programmes are highly acceptable in the Jewish community: results of the JeneScreen Study.
Tiller JM, Cousens NE, Kaur R, Rowley S, Ko YA, Mahale S, Bankier A, Meiser B, Barlow-Stewart K, Burnett L, Jacobs C, James P, Trainer A, Neil S, Campbell IG, Andrews L, Delatycki M.
Tiller JM, et al. Among authors: bankier a.
J Med Genet. 2023 Mar;60(3):265-273. doi: 10.1136/jmedgenet-2022-108519. Epub 2022 Jun 3.
J Med Genet. 2023.
PMID: 36763037